Dynamically Controlled In Situ Cascade Amplification Modulating Receptor Spatial Distribution and Cell Phenotype
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Ruxiang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory For Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, China. Hauptthemen laut MEDLINE: Ligands. Die Arbeit nennt 75 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Beijing Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Ligand‐receptor interactions play a crucial role in disease therapy. However, enhancing ligand‐receptor selectivity and precisely controlling subsequent cellular behavior remain significant challenges. In this study, we developed a receptor‐mediated cascade amplification strategy via glycopeptides (GPs) to regulate the dynamic self‐assembly of artificial ligands, enhancing ligand‐receptor selectivity. By designing the assembly sequences, we control the antagonistic relationship between dynamic nanostructures and receptor‐mediated internalization. Our findings show that in fast cascade amplification, rapid fiber network formation inhibits internalization, while in slow amplification, receptor aggregation enhances internalization, promoting cellular uptake. This precise regulation further impacts the spatial distribution and function of receptor, ultimately controlling cellular phenotypes. Based on real‐world needs, we applied the cascade amplification strategy to enhance the efficacy of PD‐L1 tumor immunotherapy. These findings provide new insights into the regulation of ligand‐receptor selectivity and receptor activity, offering promising potential for targeted enhancement and precise intervention of cellular activities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory For Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, China.
- VCANBIO Cell & Gene Engineering Corp Ltd, Tianjin, China.
- Key Laboratory of Bioactive Materials (Ministry of Education), College of Life Sciences, Nankai University, Tianjin, China.
- Fujian Key Laboratory of Women and Children' s Critical Diseases Research, Fujian Provincial Maternity and Children's Hospital, Fuzhou, China.
- School of Material Science and Engineering, Beijing Institute of Technology, Beijing, China.
- IMEIK Technology Development Co Ltd, Beijing, China.
ORCID-Profile: Ruxiang Li, Zihua Wang, Li-Li Li
Förderung
- National Key Research and Development Program of China
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- High Innovation Plan
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Li, R., Jiang, S., Zhu, Z., Chen, X., Wang, Z., & Li, L. L. (2026). Dynamically Controlled In Situ Cascade Amplification Modulating Receptor Spatial Distribution and Cell Phenotype. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71629
Vancouver
Li R, Jiang S, Zhu Z, Chen X, Wang Z, Li LL. Dynamically Controlled In Situ Cascade Amplification Modulating Receptor Spatial Distribution and Cell Phenotype. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71629
BibTeX
@article{Li2026,
author = {Li, Ruxiang and Jiang, Sujun and Zhu, Ziyu and Chen, Xiongwei and Wang, Zihua and Li, Li-Li},
title = {Dynamically Controlled In Situ Cascade Amplification Modulating Receptor Spatial Distribution and Cell Phenotype},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71629}
}
EUVIMED